References

Divergent delivery and expression kinetics of lipid and polymeric nanoparticles across mRNA modalities

10.1002/advs.202508907 · ExternalCitation · doi-reference

The interaction of innate immune and adaptive immune system

10.1002/mco2.714 · ExternalCitation · doi-reference

The signal peptide

10.1007/bf01868635 · ExternalCitation · doi-reference

Signatures of trained immunity following mRNA vaccination: differences between mRNA-1273 and BNT162b2

10.1007/s10875-025-01977-w · ExternalCitation · doi-reference

B cell responses: cell interaction dynamics and decisions

10.1016/j.cell.2019.03.016 · ExternalCitation · doi-reference

Adaptive immunity to SARS-CoV-2 and COVID-19

10.1016/j.cell.2021.01.007 · ExternalCitation · doi-reference

Clonal replacement sustains long-lived germinal centers primed by respiratory viruses

10.1016/j.cell.2022.11.031 · ExternalCitation · doi-reference

A theory of germinal center B cell selection, division, and exit

10.1016/j.celrep.2012.05.010 · ExternalCitation · doi-reference

The follicular dendritic cell: at the germinal center of autoimmunity?

10.1016/j.celrep.2024.113869 · ExternalCitation · doi-reference

Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity

10.1016/j.cmet.2016.10.008 · ExternalCitation · doi-reference

Clonal and cellular dynamics in germinal centers

10.1016/j.coi.2014.02.010 · ExternalCitation · doi-reference

Germinal center enhancement by extended antigen availability

10.1016/j.coi.2017.06.008 · ExternalCitation · doi-reference

Antigen presentation by dendritic cells for B cell activation

10.1016/j.coi.2019.04.003 · ExternalCitation · doi-reference

Innate control of adaptive immunity and adaptive instruction of innate immunity: bi-directional flow of information

10.1016/j.coi.2021.07.013 · ExternalCitation · doi-reference

PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production

10.1016/j.ijpharm.2020.119792 · ExternalCitation · doi-reference

From vaccines to memory and back

10.1016/j.immuni.2010.10.008 · ExternalCitation · doi-reference

Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes

10.1016/j.immuni.2012.07.011 · ExternalCitation · doi-reference

T follicular helper cell differentiation, function, and roles in disease

10.1016/j.immuni.2014.10.004 · ExternalCitation · doi-reference

Tissue-resident memory T cells

10.1016/j.immuni.2014.12.007 · ExternalCitation · doi-reference

CD4+ T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness

10.1016/j.immuni.2017.10.009 · ExternalCitation · doi-reference

Intratumoral Tcf1+ PD-1+ CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy

10.1016/j.immuni.2018.12.021 · ExternalCitation · doi-reference

Innate immune mechanisms of mRNA vaccines

10.1016/j.immuni.2022.10.014 · ExternalCitation · doi-reference

Immunological memory to vaccines

10.1016/j.immuni.2026.02.019 · ExternalCitation · doi-reference

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

10.1016/j.isci.2021.103479 · ExternalCitation · doi-reference

Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo

10.1016/j.isci.2024.109804 · ExternalCitation · doi-reference

Present yourself! By MHC class I and MHC class II molecules

10.1016/j.it.2016.08.010 · ExternalCitation · doi-reference

Antigen presentation to B cells

10.1016/j.it.2016.10.003 · ExternalCitation · doi-reference

Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches

10.1016/j.jpha.2024.100996 · ExternalCitation · doi-reference

Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines

10.1016/j.omtn.2019.01.013 · ExternalCitation · doi-reference

mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells

10.1016/j.ymthe.2022.07.007 · ExternalCitation · doi-reference

CircRNA: unlocking new frontiers in therapeutic and vaccine development

10.1016/j.ymthe.2025.10.038 · ExternalCitation · doi-reference

STING agonist-derived LNP-mRNA vaccine enhances protective immunity against SARS-CoV-2

10.1021/acs.nanolett.2c04883 · ExternalCitation · doi-reference

Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine

10.1021/acsnano.2c04543 · ExternalCitation · doi-reference

Iterative design of ionizable lipids for intramuscular mRNA delivery

10.1021/jacs.2c10670 · ExternalCitation · doi-reference

Fluorinated ionizable lipids for efficient spleen-targeted mRNA delivery in cancer immunotherapy

10.1021/jacs.5c13982 · ExternalCitation · doi-reference

Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells

10.1038/87720 · ExternalCitation · doi-reference

Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability

10.1038/mt.2008.200 · ExternalCitation · doi-reference

Adaptive immune features of natural killer cells

10.1038/nature07665 · ExternalCitation · doi-reference

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

10.1038/nature18300 · ExternalCitation · doi-reference

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

10.1038/nature23003 · ExternalCitation · doi-reference

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

10.1038/ni.1863 · ExternalCitation · doi-reference

Immunological mechanisms of vaccination

10.1038/ni.2039 · ExternalCitation · doi-reference

The developmental pathway for CD103+ CD8+ tissue-resident memory T cells of skin

10.1038/ni.2744 · ExternalCitation · doi-reference

Molecular regulation of effector and memory T cell differentiation

10.1038/ni.3031 · ExternalCitation · doi-reference

A human memory T cell subset with stem cell–like properties

10.1038/nm.2446 · ExternalCitation · doi-reference

T memory stem cells in health and disease

10.1038/nm.4241 · ExternalCitation · doi-reference

Engineering synthetic vaccines using cues from natural immunity

10.1038/nmat3775 · ExternalCitation · doi-reference

mRNA vaccines—a new era in vaccinology

10.1038/nrd.2017.243 · ExternalCitation · doi-reference

mRNA-based therapeutics—developing a new class of drugs

10.1038/nrd4278 · ExternalCitation · doi-reference

Immunological memory: lessons from the past and a look to the future

10.1038/nri.2016.13 · ExternalCitation · doi-reference

A guide to immunometabolism for immunologists

10.1038/nri.2016.70 · ExternalCitation · doi-reference

The who, how and where of antigen presentation to B cells

10.1038/nri2454 · ExternalCitation · doi-reference

Towards a systems understanding of MHC class I and MHC class II antigen presentation

10.1038/nri3084 · ExternalCitation · doi-reference

Transcriptional control of effector and memory CD8+ T cell differentiation

10.1038/nri3307 · ExternalCitation · doi-reference

The integration of T cell migration, differentiation and function

10.1038/nri3442 · ExternalCitation · doi-reference

Regulation of type I interferon responses

10.1038/nri3581 · ExternalCitation · doi-reference

Follicular dendritic cells: dynamic antigen libraries

10.1038/nri3689 · ExternalCitation · doi-reference

The generation of antibody-secreting plasma cells

10.1038/nri3795 · ExternalCitation · doi-reference

A brief history of T cell help to B cells

10.1038/nri3803 · ExternalCitation · doi-reference

The ins and outs of MHC class II-mediated antigen processing and presentation

10.1038/nri3818 · ExternalCitation · doi-reference

Molecular and cellular insights into T cell exhaustion

10.1038/nri3862 · ExternalCitation · doi-reference

Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics

10.1038/s12276-023-01086-x · ExternalCitation · doi-reference

Tissue resident memory T cells in the respiratory tract

10.1038/s41385-021-00461-z · ExternalCitation · doi-reference

mRNA-based therapeutics: powerful and versatile tools to combat diseases

10.1038/s41392-022-01007-w · ExternalCitation · doi-reference

Nucleic acid drugs: recent progress and future perspectives

10.1038/s41392-024-02035-4 · ExternalCitation · doi-reference

Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion

10.1038/s41392-025-02327-3 · ExternalCitation · doi-reference

B cell memory: from generation to reactivation: a multipronged defense wall against pathogens

10.1038/s41420-024-01889-5 · ExternalCitation · doi-reference

Ionizable lipid nanoparticles of mRNA vaccines elicit NF-κB and IRF responses through toll-like receptor 4

10.1038/s41541-025-01124-x · ExternalCitation · doi-reference

Synergistic effect of nucleoside modification and ionizable lipid composition on translation and immune responses to mRNA vaccines

10.1038/s41541-025-01263-1 · ExternalCitation · doi-reference

Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms

10.1038/s41541-025-01302-x · ExternalCitation · doi-reference

Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

10.1038/s41551-021-00786-x · ExternalCitation · doi-reference

Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA

10.1038/s41551-023-01082-6 · ExternalCitation · doi-reference

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing

10.1038/s41565-020-0669-6 · ExternalCitation · doi-reference

Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines

10.1038/s41565-023-01404-4 · ExternalCitation · doi-reference

Emerging concepts in the science of vaccine adjuvants

10.1038/s41573-021-00163-y · ExternalCitation · doi-reference

Integrative single-cell analysis

10.1038/s41576-019-0093-7 · ExternalCitation · doi-reference

Defining ‘T cell exhaustion’

10.1038/s41577-019-0221-9 · ExternalCitation · doi-reference

B cell memory: building two walls of protection against pathogens

10.1038/s41577-019-0244-2 · ExternalCitation · doi-reference

Defining trained immunity and its role in health and disease

10.1038/s41577-020-0285-6 · ExternalCitation · doi-reference

The germinal centre B cell response to SARS-CoV-2

10.1038/s41577-021-00657-1 · ExternalCitation · doi-reference

Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines

10.1038/s41577-022-00825-x · ExternalCitation · doi-reference

Lipid nanoparticles for mRNA delivery

10.1038/s41578-021-00358-0 · ExternalCitation · doi-reference

Molecular mechanisms and cellular functions of cGAS–STING signalling

10.1038/s41580-020-0244-x · ExternalCitation · doi-reference

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion

10.1038/s41586-019-1325-x · ExternalCitation · doi-reference

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

10.1038/s41586-021-03738-2 · ExternalCitation · doi-reference

Germinal Centre-driven maturation of B cell response to mRNA vaccination

10.1038/s41586-022-04527-1 · ExternalCitation · doi-reference

Algorithm for optimized mRNA design improves stability and immunogenicity

10.1038/s41586-023-06127-z · ExternalCitation · doi-reference

Transfer learning enables predictions in network biology

10.1038/s41586-023-06139-9 · ExternalCitation · doi-reference

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC

10.1038/s41586-025-10004-2 · ExternalCitation · doi-reference

A comparison of single-cell trajectory inference methods

10.1038/s41587-019-0071-9 · ExternalCitation · doi-reference

Human 5′ UTR design and variant effect prediction from a massively parallel translation assay

10.1038/s41587-019-0164-5 · ExternalCitation · doi-reference

Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy

10.1038/s41587-024-02490-y · ExternalCitation · doi-reference

IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines

10.1038/s41590-022-01160-y · ExternalCitation · doi-reference

Method of the year: spatially resolved transcriptomics

10.1038/s41592-020-01033-y · ExternalCitation · doi-reference

scGPT: toward building a foundation model for single-cell multi-omics using generative AI

10.1038/s41592-024-02201-0 · ExternalCitation · doi-reference

Large-scale foundation model on single-cell transcriptomics

10.1038/s41592-024-02305-7 · ExternalCitation · doi-reference

Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery

10.1038/s41596-022-00755-x · ExternalCitation · doi-reference

Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration

10.1038/s42003-021-02441-2 · ExternalCitation · doi-reference

Design principles of lipid nanoparticles for RNA delivery

10.1038/s44222-026-00401-1 · ExternalCitation · doi-reference

Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages

10.1038/s44320-025-00093-6 · ExternalCitation · doi-reference

Duration of humoral immunity to common viral and vaccine antigens

10.1056/nejmoa066092 · ExternalCitation · doi-reference

Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery

10.1073/pnas.1008437107 · ExternalCitation · doi-reference

Systems vaccinology: probing humanity’s diverse immune systems with vaccines

10.1073/pnas.1400476111 · ExternalCitation · doi-reference

Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination

10.1073/pnas.1606050113 · ExternalCitation · doi-reference

High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing

10.1073/pnas.1811276115 · ExternalCitation · doi-reference

mRNA structure regulates protein expression through changes in functional half-life

10.1073/pnas.1908052116 · ExternalCitation · doi-reference

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

10.1073/pnas.92.25.11671 · ExternalCitation · doi-reference

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

10.1084/jem.20171450 · ExternalCitation · doi-reference

Integrated mRNA sequence optimization using deep learning

10.1093/bib/bbad001 · ExternalCitation · doi-reference

Light attention predicts protein location from the language of life

10.1093/bioadv/vbab035 · ExternalCitation · doi-reference

Metabolic adaptations driving innate immune memory: mechanisms and therapeutic implications

10.1093/jleuko/qiaf037 · ExternalCitation · doi-reference

Lipid nanoparticle: beyond delivery vehicle—unveiling its immunological adjuvant potential

10.1096/fj.202500622r · ExternalCitation · doi-reference

Will systems biology deliver its promise and contribute to the development of new or improved vaccines? From data to understanding through systems biology

10.1101/cshperspect.a028894 · ExternalCitation · doi-reference

The role of the interleukin-1 family in trained immunity

10.1111/imr.12617 · ExternalCitation · doi-reference

Metabolic switching and fuel choice during T-cell differentiation and memory development

10.1111/j.1600-065x.2012.01150.x · ExternalCitation · doi-reference

The evolving role of tissue-resident memory T cells in infections and cancer

10.1126/sciadv.abo5871 · ExternalCitation · doi-reference

mTOR-and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity

10.1126/science.1250684 · ExternalCitation · doi-reference

Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity

10.1126/science.1251086 · ExternalCitation · doi-reference

Immunological memory and protective immunity: understanding their relation

10.1126/science.272.5258.54 · ExternalCitation · doi-reference

Trained immunity: a program of innate immune memory in health and disease

10.1126/science.aaf1098 · ExternalCitation · doi-reference

Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer

10.1126/science.abb9847 · ExternalCitation · doi-reference

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

10.1126/science.abm0829 · ExternalCitation · doi-reference

Evolutionary-scale prediction of atomic-level protein structure with a language model

10.1126/science.ade2574 · ExternalCitation · doi-reference

Deep generative models design mRNA sequences with enhanced translational capacity and stability

10.1126/science.adr8470 · ExternalCitation · doi-reference

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

10.1126/scitranslmed.ady6831 · ExternalCitation · doi-reference

Correlates of protection induced by vaccination

10.1128/cvi.00131-10 · ExternalCitation · doi-reference

Germinal centers

10.1146/annurev-immunol-020711-075032 · ExternalCitation · doi-reference

Systems biology in immunology: a computational modeling perspective

10.1146/annurev-immunol-030409-101317 · ExternalCitation · doi-reference

Systems immunology: learning the rules of the immune system

10.1146/annurev-immunol-042617-053035 · ExternalCitation · doi-reference

Tissue-resident T cells and other resident leukocytes

10.1146/annurev-immunol-042617-053214 · ExternalCitation · doi-reference

Trained immunity: reprogramming innate immunity in health and disease

10.1146/annurev-immunol-102119-073855 · ExternalCitation · doi-reference

Germinal centers

10.1146/annurev-immunol-120419-022408 · ExternalCitation · doi-reference

The use of RNA-based treatments in the field of cancer immunotherapy

10.1186/s12943-023-01807-w · ExternalCitation · doi-reference

Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications

10.1186/s12985-025-02645-6 · ExternalCitation · doi-reference

Eleven grand challenges in single-cell data science

10.1186/s13059-020-1926-6 · ExternalCitation · doi-reference

Zero-shot evaluation reveals limitations of single-cell foundation models

10.1186/s13059-025-03574-x · ExternalCitation · doi-reference

Current best practices in single-cell RNA-seq analysis: a tutorial

10.15252/msb.20188746 · ExternalCitation · doi-reference

mRNA: a versatile molecule for cancer vaccines

10.21775/cimb.022.113 · ExternalCitation · doi-reference

How follicular dendritic cells shape the B-cell antigenome

10.3389/fimmu.2016.00225 · ExternalCitation · doi-reference

Striking a balance—cellular and molecular drivers of memory T cell development and responses to chronic stimulation

10.3389/fimmu.2019.01595 · ExternalCitation · doi-reference

Increased B cell selection stringency in germinal centers can explain improved COVID-19 vaccine efficacies with low dose prime or delayed boost

10.3389/fimmu.2021.776933 · ExternalCitation · doi-reference

Role of B cells as antigen presenting cells

10.3389/fimmu.2022.954936 · ExternalCitation · doi-reference

Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells?

10.3389/fimmu.2023.1216402 · ExternalCitation · doi-reference

Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice

10.3389/fimmu.2023.1249902 · ExternalCitation · doi-reference

Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design

10.3389/fimmu.2023.1294929 · ExternalCitation · doi-reference

Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection

10.3389/fimmu.2024.1445653 · ExternalCitation · doi-reference

Circular RNA, the key for translation

10.3390/ijms21228591 · ExternalCitation · doi-reference

Opportunities and challenges in the delivery of mRNA-based vaccines

10.3390/pharmaceutics12020102 · ExternalCitation · doi-reference

The importance of poly (ethylene glycol) and lipid structure in targeted gene delivery to lymph nodes by lipid nanoparticles

10.3390/pharmaceutics12111068 · ExternalCitation · doi-reference

mRNA vaccine nanoplatforms and innate immunity

10.3390/v16010120 · ExternalCitation · doi-reference

Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines

10.3390/vaccines11030658 · ExternalCitation · doi-reference

Memory cells in infection and autoimmunity: mechanisms, functions, and therapeutic implications

10.3390/vaccines13020205 · ExternalCitation · doi-reference

Decrypting the immune symphony for RNA vaccines

10.3390/vaccines13080882 · ExternalCitation · doi-reference

Development of mRNA vaccines: scientific and regulatory issues

10.3390/vaccines9020081 · ExternalCitation · doi-reference

An update on self-amplifying mRNA vaccine development

10.3390/vaccines9020097 · ExternalCitation · doi-reference

Antigen presentation of mRNA-based and virus-vectored SARS-CoV-2 vaccines

10.3390/vaccines9080848 · ExternalCitation · doi-reference

mRNA COVID-19 vaccines and long-lived plasma cells: a complicated relationship

10.3390/vaccines9121503 · ExternalCitation · doi-reference

Antigen presentation to B cells

10.3410/b2-87 · ExternalCitation · doi-reference

Duration of antigen availability influences the expansion and memory differentiation of T cells

10.4049/jimmunol.1100363 · ExternalCitation · doi-reference

Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals

10.4049/jimmunol.180.1.309 · ExternalCitation · doi-reference

The use of signal peptide domains as vaccine candidates

10.4161/21645515.2014.970916 · ExternalCitation · doi-reference